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Background: This study explores the impact of weight gain during medical stabilization
hospitalization on weight outcomes between three outpatient treatments for adolescent
anorexia nervosa (AN): Adolescent Focused Therapy (AFT), Systemic Family Therapy
(SyFT), and Family Based Treatment (FBT).
Methods: A secondary analysis of weight gain data (N = 215) of adolescents (12–18
years) meeting DSM-IV criteria for AN (exclusive of amenorrhea criteria) who participated
in two randomized clinical trials (RCTs) was conducted. Main outcomes examined were
changes in weight restoration (≥95% expected body weight or EBW) and differences in
weight change attributable to hospital weight gain.
Results: Weight gain resulting from hospitalizations did not substantially change weight
recovery rates. Hospital weight gain contributed most to overall treatment weight gain in
AFT compared to FBT and SyFT.
Conclusion: Brief medical stabilization weight gain does not contribute substantially to
weight recovery in adolescents with AN who participated in RCTs.
Keywords: anorexia, hospitalization, inpatient, weight gain, treatment outcome, adolescent
INTRODUCTION
Medical hospitalization to address the physiological effects of starvation and related maintaining
behaviors of Anorexia Nervosa (AN) plays an important role when treating adolescents with
AN. However, the extent to which hospitalization contributes to weight restoration is unclear.
The few available studies suggest limited impact (1, 2). Madden et al. (3) found no benefit of
longer term hospitalization aimed at achieving higher weights for patients receiving Family-based
Treatment (FBT) upon discharge, suggesting that limited hospital stays were sufficient
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for these patients. Additionally, prior studies found that
hospitalization rates differ between outpatient treatments
for adolescents with AN, leading to significant differences in
cost-effectiveness between treatment types (4, 5). However,
it is unknown whether hospitalization during evidence-
based outpatient treatments for adolescent AN differentially
contributes to overall weight outcomes depending on treatment
type. Thus, the purpose of this retrospective exploratory study
is to examine the relative impact of hospital weight gain on
treatment outcomes [i.e., weight restoration: ≥95% expected
body weight (EBW)] (6, 7) in the context of three outpatient
treatments: FBT (8), Adolescent Focused Therapy (AFT) (9),
and Systemic Family Therapy (SyFT) (10), employed in two
randomized clinical trials (RCTs) for adolescents with AN.
While hospitalization for psychiatric and behavioral treatment
of adolescent AN is a potentially important component of
care and outcome, the current study focuses on the role of
brief medical hospitalization used to treat medically unstable
adolescents with AN in studies of outpatient psychosocial
interventions for this disorder. These hospitalizations are
unplanned and occur in response to medical instability. Medical
instability results from physiological impacts of behaviors that
maintain AN and can result in bradycardia, hypotension, and
orthostatic hypotension (11). In addition, starvation and rapid
re-feeding can result in blood chemistry changes leading to
potentially lethal re-feeding syndrome (12). Treatments during
medical hospitalization vary, but in general these admissions
focus on promoting safe but rapid weight gain through closemeal
monitoring, limited activity, focused psychological support for
patients and parents, and preparation for discharge to outpatient
care (13). Lengths of stay for medical hospitalization vary but
are usually between 1 and 3 weeks for adolescents in the US and
Canada (14, 15).
There are few RCTs for adolescent AN; two relatively large
studies examined individual therapy aimed at promoting
adolescent development in the context of AN (AFT),
systemic family therapy (SyFT) aimed at improving family
communication and process in the context of AN, and family-
based treatment (FBT) aimed at parental behavioral management
of weight gain and adolescent development (4, 5). Results of
these RCTs found that FBT had higher rates of recovery than
AFT at follow-up and was more cost-effective than SyFT.
While previous studies demonstrate that FBT generally uses
less medical hospitalization than AFT and SyFT (4, 5), the impact
of hospitalization on weight gain itself is unaccounted for in
the outcomes. Thus, weight gain during hospital admissions
might vary between treatment types and contribute differentially
to weight restoration. Based on the previous studies we expect
that when looking at the entire sample (both hospitalized and
non-hospitalized participants), hospital weight gain will likely
have minimal effects on weight recovery rates, or remission,
regardless of treatment type. When looking at the impact
of hospitalization weight gain on end-of-treatment (EOT)
weight outcomes, we predict differing effects of hospitalization
depending on treatment type. Specifically, we anticipate greater
overall impacts on weight at EOT for participants receiving
individual treatment (AFT) compared to family treatment (FBT
or SyFT). This hypothesis is rooted in prior literature (4),
reporting that in AFT, alliance building and relatedly weight
progress takes longer than in FBT, resulting in a prolonged
period of time during which the adolescent is more medically
vulnerable. Hospitalization for adolescents receiving AFT may
serve as a “safety net” while they develop the motivation and
skills to change behaviors independently. These hypotheses are
exploratory due to the preliminary nature of this study. Results
stand to inform future systematic studies designed to investigate
the role of hospitalization on weight outcomes in adolescents
receiving evidence-based treatments for AN.
MATERIALS AND METHODS
Data used in this study were collected from two RCTs
of adolescents (ages 12–18) who met DSM-IV criteria for
AN (exclusive of amenorrhea criteria). The first clinical trial
randomized participants (N = 121) to receive either FBT or AFT
in a two-site study (4); the current data are only those recruited
at the Stanford site (N = 60), as The University of Chicago
did not have a dedicated inpatient unit and participants were
admitted, when appropriate, to facilities outside of the university.
The second clinical trial randomized participants (N = 158) to
receive FBT or SyFT in a 6-site study (5). For this paper, the FBT
samples from the two RCTs were combined. The studies were
reviewed and approved by their respective Institutional Review
Boards and all participants provided written informed consent
or assent.
The criteria for hospitalization at the time of the study
followed the guidelines of the American Academy of Pediatrics
(16) and the Society for Adolescent Medicine (17) for medical
hospitalization of adolescents with AN: heartrate <45 beats-
per-minute, orthostatic blood pressure changes >35 points,
gastrointestinal bleeding, dizziness, syncope, EBW <75%, body
temperature below 36◦C, electrolyte abnormalities, and/or
prolonged QTc. Using these criteria, a total of 59 participants
(27%) were hospitalized for medical reasons during the treatment
period of the two studies: AFT = 48% (16/33); SyFT = 22%
(17/79); FBT= 19% (20/106).
Demographic characteristics of the hospitalized sample can
be found in Table 1. The outcome variables of interest were:
(1) Hospitalization days and number of admissions for medical
stabilization by treatment type; (2) Total hospital weight gain;
(3) Treatment weight gain; (4) Change in EOT weight outcomes
(defined as EBW percent for age, height, and sex, using CDC
norms) from baseline to EOT; (5) Timing of hospitalization
(weeks in treatment until first hospitalization). Weight was
measured and is reported in kilograms.
The effect of hospitalization on weight outcomes according
to treatment allocation was calculated by subtracting the mean
hospital weight gain from the mean weight gain at EOT for
each individual participant and from this, calculating a mean
difference score for weight. This new “adjusted” weight was then
used to re-calculate percent EBW for age, height and sex using
CDC norms, producing an “adjusted EBW” for each participant,
accounting for hospitalization weight gain. Weight recovery or
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TABLE 1 | Demographics by treatment type.
AFT (N = 33) SyFT (N = 79) FBT (N = 106)
Age M (SD) 14.7 (1.3) 15.0 (2.4) 14.4 (1.7)
Sex (%)
Male 3% 7.6% 13.2%
Female 97% 91.1% 86.8%
Race (%)
Asian 18.2% 5.1% 10.4%
Black or African American 3% – –
White 72.7% 92.4% 82.1%
More than one race 6.1%% 2.5% 7.5%
Ethnicity (%)
Hispanic/latino 6.1% 12.7% 11.3%
Not hispanic/latino 93.9% 87.3% 88.7%
Baseline % EBW M (SD) 80.0 (3.8) 81.8 (3.7) 82.1 (3.6)
Medications at baseline (%) 6% 37.9% 24.5%
remission was defined as ≥95% EBW, consistent with prior
research demonstrating this criterion as the best predictor for
long-term recovery (6, 7). The entire sample, including those
not hospitalized, was assessed to calculate differences in number
of people meeting weight recovery after accounting for hospital
weight gain.
Timing (by weeks of treatment) of hospitalizations was
determined by average number of weeks in treatment to first
hospitalization by group and number of weeks in treatment to
each admission thereafter (if there were multiple admissions).
Frequency of hospitalizations and multiple admissions were not
controlled for in the current analyses.
Data were analyzed using SPSS version 26.0. Analyses
involving the subset of participants who were hospitalized were
not normally distributed and had unequal cell sizes, thus non-
parametric statistics and post-hoc analyses were utilized. All
measures of central tendency reported are medians (Mdn) with
Interquartile Ranges (IQR) or frequencies (count). Due to the
exploratory nature of this study, we report effect sizes (ES) for
comparisons, specifically, success rate differences (SRD).
RESULTS
For those hospitalized during the study, the median number of
hospitalized days in SyFT was 23 (IQR = 15–31), compared to a
median of 6 days in AFT (IQR= 4–14) and 9.5 days in FBT (IQR
= 5–16.8).
Weight Remission
Medical hospitalization had little effect on the number of
participants who were weight recovered at EOT. When
accounting for weight gained during hospitalization, the recovery
rates in each group were: FBT = 44/106 or 41.5% (unchanged);
SyFT= 21/79 or 26.6% (vs. 27.8%when including hospitalization
weight gain); AFT = 6/33 or 18.2% (vs. 21.2% when including
hospitalization weight gain).
Weight Change
Hospitalization impact on weight outcomes for the entire
sample differed depending on the type of outpatient treatment:
hospitalization contributed most to EOT weight outcomes in
AFT where 7.2% of EBW was attributable to hospital weight
gain (Table 2). For SyFT and FBT, hospital weight gain did not
contribute to EBW at EOT. The differences in percent EBW at
EOT after removing hospital weight gain (i.e., “adjusted EBW”)
differed between treatment arms with large effect sizes, with AFT
< SyFT:Mann-WhitneyU = 773.5; SRD= 0.40 andAFT< FBT:
Mann-Whitney U = 901.5; SRD= 0.48.
Timing of Hospitalization
For FBT and SyFTmore than half of all hospitalizations occurred
within the first 5 weeks of treatment. In FBT, 54% of the sample
was hospitalized within the first 5 weeks (n = 14/26) and in
SyFT, 57% of the sample was hospitalized within the first 5 weeks
(n = 11/19). In contrast, in AFT, only 29% (n = 13/42) of
hospitalizations occurred within the first 5 weeks of treatment.
Additionally, 50% (n = 8/16) of hospitalized participants in AFT
had multiple admissions, whereas 29% (n = 5/17) in SyFT and
25% (n = 5/20) in FBT had multiple admissions.
DISCUSSION
These results support our first exploratory hypothesis that weight
gain attributable to medical hospitalization would have little
impact on EOT weight restoration, regardless of outpatient
treatment type. This is an important finding because it supports
the view that outpatient treatment is the most salient factor
in overall weight restoration for adolescent AN. This is not
to suggest that medical hospitalization is not necessary for
the safe treatment of adolescent AN, but rather to recognize
that the effects of such treatments on weight restoration are
circumscribed. These results are aligned with prior literature (3),
reporting medical stabilization alone when followed by FBT was
as effective and less costly than longer term hospitalization aimed
at full weight restoration.
Consistent with our second exploratory hypothesis predicting
differing impacts of hospitalization according to treatment
type, the data show that hospitalization weight gain had
the greatest benefit for those treated using AFT relative
to SyFT and FBT. AFT relies on helping the adolescent
with AN learn to manage their eating and weight gain
as opposed to parental management, thus hospitalization is
likely to be needed more often to mitigate health risks as
the adolescents themselves are learning to make necessary
behavioral changes.
There are important limitations to consider. This secondary
data analysis is exploratory in design, intended to generate
hypotheses for further examination rather than conduct
significance testing. The sample size, especially for AFT, is
limited because the data is not available; to address the
disproportionate sample sizes between groups, non-parametric
statistics are reported. Although differences in hospitalized and
non-hospitalized participants were not apparent at baseline, the
data support existing literature that hospitalization is sometimes
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TABLE 2 | Hospitalization outcomes†.
Entire sample AFT (N = 33) SyFT (N = 79) FBT (N = 106) SRD‡
% of total sample hospitalized 49% 22% 19%
Number of admissions 42 19 26
Number of patients with repeat admissions 8 of 33 5 of 79 5 of 106
Weight gained in treatment (kg) 5 (1.6–7.9) 4.9 (2.3–8.7) 5.9 (3.5–10.2)
% EBW EOT 89 (79.6–93.9) 89 (84.1–95.3) 92.6 (86.2–98.1)
% EBW “adjusted” (hospital weight gain removed) 81.8 (75.9–92.9) 88.9 (84.1–95.4) 92.6 (86–96.9) AFT<SyFT: 0.40
AFT<FBT: 0.48
% change in EBW attributable to hospitalization 7.2% 0% 0%
Number of patients ≥95% EBW 7 22 44
% of total sample weight restored 21.2% 27.8% 41.5%
Number of patients ≥95% EBW (after removing hospital weight gain) 6 (vs. 7) 21 (vs. 22) 44 (vs. 44)
Adjusted % of total sample weight restored 18.2% 26.6% 41.5%
Hospitalized Sample AFT (N = 16) SyFT (N = 17) FBT (N = 20) SRD‡
Median number of days hospitalized 6 (4–14) 23 (15–31) 9.5 (5–16.8) SFT>FBT: 0.54
SFT>AFT: 0.69
Weight gained in treatment (kg) 3.9 (2–5.7) 3.5 (2–5) 3.1 (1.5–6.6)
% EBW EOT 88 (77.8–94.9) 83.7 (80.1–94.2) 92 (79.7–101.2)
% EBW “adjusted” (hospital weight gain removed) 78 (71.3–89.74) 78.9 (73.7–92.4) 92 (73.3–96.7)
†
All statistics are reported medians (Mdn) and interquartile range (IQR) unless otherwise specified. ‡Effect size used is success rate difference (SRD) given the use of pairwise comparisons
of treatments with unequal variances. Here, SRD = 0.1, 0.3, 0.4 can be interpreted as small, medium, and large effect sizes, respectively (18).
necessary to stabilize adolescents for outpatient care. For this
subset of patients, it is possible that hospital admissions helped
correct the course of treatment by allowing patients to stabilize
vital signs and resume outpatient therapy. The outcome assessed
is only related to weight restoration at EOT; while predictive
of overall recovery at follow-up, it remains a limited outcome
variable (6). Hospitalization in this study was restricted to
medical necessity and the findings should not be extended to
the use of psychiatric or behavioral hospitalization for adolescent
AN or to other countries, health systems, or programs that
use hospitalization for different indications in AN. There was
a slight difference in treatment length and duration in the FBT
treatment studies (24 sessions over 12 months vs. 16 sessions
over 9 months), but this difference likely had little impact on
hospital use, as almost all hospitalizations in FBT occurred
early in treatment regardless of overall number of sessions or
duration of treatment. While medical hospitalization criteria
were consistent across sites and treatments, these criteria have
not been systematically examined to determine their validity
and reliability in preventing or limiting the medical sequelae of
adolescent AN. Further, not all participants were admitted to the
same medical hospitalization program; thus, it is possible that
inpatient programming may differ across hospitalization sites
and lead to differences in rate of weight gain. Across the seven
sites, average hospitalization length of stay ranged from M =
7.6, SD = 2.1 to M = 21, SD = 2.The study’s small sample
size limited further investigation into site-related differences.
The study’s small sample size limited further investigation into
site-related differences. Additionally, while all participants in
this study were hospitalized consistent with published medical
guidelines, we do not have data specific to the circumstances
which preceded each hospitalization. Sex differences between
treatment groups did not reach statistical significance (p =
0.14); however, it is possible that the distribution of sex across
groups may have differentially impacted weight outcomes.
Lastly, no hospitalized participants identified as American
Indian or Alaska Native, and Native Hawaiian or Other Pacific
Islander, which may limit generalizability of findings to these
minority groups.
The results of this exploratory study suggest that further
investigation of the role of medical hospitalization for adolescent
AN is warranted. Additionally, clinicians providing AFT, FBT,
and SyFT should be confident that these outpatient approaches,
though varying in overall rates of recovery, do not obtain their
respective treatment effects based on weight restoration as a
result of medical hospitalization.
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